Health Secretary Robert F. Kennedy Jr. has launched an initiative to help Americans wean off antidepressants, sparking debate among mental health experts over the merits and risks of his deprescribing campaign. Kennedy announced the MAHA initiative at a mental health summit, continuing a long-held position that psychiatric drugs like SSRIs are harmful, including claims they cause mass shootings.
Mixed Expert Response
The American Psychiatric Association’s president, Theresa Miskimen Rivera, told NPR that Kennedy’s perspective “really is an oversimplification” that “ignores the larger reality” that too many patients cannot access timely, comprehensive care. The association supports “any plans to better train healthcare providers to safely prescribe and wean patients off antidepressants,” but not Kennedy’s broader approach. Clinical professor Jonathan Slater at Columbia University noted there is “a legitimate clinical problem” at the center of deprescribing: it is “understudied, undertaught and under-reimbursed.” However, redirecting patients away from medications is “only clinically responsible if the alternatives are accessible. They are not.”
Overlooking Systemic Issues
Critics argue Kennedy’s campaign conveniently sidesteps structural problems that force people to rely on SSRIs. The approach overlooks that American psychiatry has “willfully blinded itself” to withdrawal and discontinuation difficulties from antidepressants, according to clinical associate professor Awais Aftab. Some experts acknowledge Kennedy gets part of the diagnosis right: overmedicalization is a genuine concern, and pharmaceutical companies have promoted the false belief that drugs correct a chemical imbalance in the brain. However, the MAHA movement’s approach places responsibility on individuals rather than addressing the exploitative systems creating poor mental health in the first place.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://theweek.com/health/what-maha-gets-right-and-wrong-about-deprescribing-ssris